The trial was meant to answer the biggest question in biotech: What happens when U.S. companies test promising new Chinese ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; ...

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...

GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase ...

Healthcare & Pharmaceuticalscategory· May 8, 2025 India's Biocon posts higher quarterly profit on boost from generics, biosimilar business Indian biopharma firm Biocon's profit more than doubled ...

Dr. Raza Bokhari, Company’s Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 YearsTORONTO, May 30, 2025 (GLOBE ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

To meet these demands, biopharma leaders are rethinking their digital infrastructure. Integrated informatics platforms—once ...

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

A $2.35 million settlement had ended litigation between a Canadian life sciences company and its former Philadelphia-based ...